Condition

Acute Myeloid Leukemia in Remission clinical trials and research

• 6Clinical trials
• 3Countries

Newest Acute Myeloid Leukemia in Remission clinical trials

All recruiting trials (6)

• Preventing GvHD in patients with blood cancers undergoing stem cell transplants

  This study is testing a new treatment called TRX-103 to see if it can help prevent graft-versus-host disease in people with blood cancers who are getting stem cell transplants from mismatched donors.

  Recruiting at 5 sites Phase 1 Tr1X, Inc. · Duarte, California and 4 other locations · NCT06462365

• Ziftomenib treatment after blood cancer transplant

  This study is testing if ziftomenib can help people with acute myeloid leukemia feel better and stay healthy after a blood cancer transplant.

  Recruiting at 2 sites Phase 1 Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT06440135

• Comparing two treatment regimens for adults with acute myeloid leukemia before stem cell transplant

  This study is testing if a treatment using Clofarabine helps adults with acute myeloid leukemia live longer after a stem cell transplant compared to another treatment with Fludarabine.

  Recruiting at 20 sites Phase 2 Nantes University Hospital · Nantes, Loire Atlantique and 22 other locations · NCT05917405

• Targeted T-Cell and B-Cell Depletion for Hematologic Malignancies

  This study is testing a new way to prepare patients with blood cancers for stem cell transplants by removing certain immune cells to see if it helps them recover better and stay healthy longer.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT05794880

• Comparing two conditioning regimens for allogeneic hematopoietic cell transplantation

  This study is testing two different treatment plans for patients with blood cancers who are getting stem cell transplants from matched donors to see which one helps them stay healthy longer.

  Recruiting at 10 sites Phase 2 University of Liege · Antwerp and 9 other locations · NCT03852407

• Using a radioactive antibody followed by stem cell transplant to treat high-risk leukemia or myelodysplastic syndrome

  This study is testing a new radioactive treatment combined with a stem cell transplant to see if it can help people with high-risk leukemia or myelodysplastic syndrome feel better and improve their chances of recovery.

  Recruiting Phase 1/2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT03670966

Related topics

Quick answers

How many Acute Myeloid Leukemia in Remission clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (4 trials), France (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →